Literature DB >> 19503954

Global burden of disease attributable to diabetes mellitus in Brazil.

Andreia Ferreira de Oliveira1, Joaquim Gonçalves Valente, Iuri da Costa Leite, Joyce Mendes de Andrade Schramm, Anne S Renteria de Azevedo, Angela Maria Jourdan Gadelha.   

Abstract

Type II diabetes mellitus accounts for 90% of all cases of diabetes, and its inclusion in health evaluation has shown that its complications have a considerable impact on the population's quality of life. The current article presents the results of the Global Burden of Disease Study in Brazil for the year 1998, with an emphasis on diabetes mellitus and its complications. The indicator used was disability-adjusted life years (DALY), using a discount rate of 3%. In Brazil, ischemic heart disease, stroke, and diabetes accounted for 14.7% of total lost DALYs. Brazil showed a higher proportion of years lived with disability (YLDs) among total DALYs for diabetes as compared to other countries. Retinopathy and neuropathy were the complications that contributed most to YLDs. According to forecasts, diabetes mellitus will have an increasing impact on years of life lost due to premature death and disability in the world, shifting from the 11th to 7th cause of death by 2030. It is thus urgent to implement effective measures for prevention, early diagnosis, counseling, and adequate follow-up of patients with diabetes mellitus.

Entities:  

Mesh:

Year:  2009        PMID: 19503954     DOI: 10.1590/s0102-311x2009000600006

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  12 in total

1.  Mindfulness-Based Stress Reduction and Diabetes.

Authors:  Robin R Whitebird; Mary Jo Kreitzer; Patrick J O'Connor
Journal:  Diabetes Spectr       Date:  2009-09-21

Review 2.  Treating Diabetic Neuropathy: Present Strategies and Emerging Solutions.

Authors:  Saad Javed; Uazman Alam; Rayaz A Malik
Journal:  Rev Diabet Stud       Date:  2015-08-10

3.  Days lost due to disability of diclofenac-induced adverse drug reactions.

Authors:  Dixon Thomas; Molly Mathew; C Vijaya Raghavan; Guru P Mohanta; Y Padmanabha Reddy
Journal:  Pharm Pract (Granada)       Date:  2012-03-31

4.  Sex Differences in Diabetes Mellitus Mortality Trends in Brazil, 1980-2012.

Authors:  Thainá Alves Malhão; Alexandre Dos Santos Brito; Rejane Sobrino Pinheiro; Cristiane da Silva Cabral; Thais Medina Coeli Rochel de Camargo; Claudia Medina Coeli
Journal:  PLoS One       Date:  2016-06-08       Impact factor: 3.240

5.  The burden of diabetes in Argentina.

Authors:  Lorena Gonzalez; Joaquin E Caporale; Jorge F Elgart; Juan J Gagliardino
Journal:  Glob J Health Sci       Date:  2014-11-17

6.  Prevalence and factors associated with lower limb amputation in individuals with type II diabetes mellitus in a referral hospital in Fortaleza, Ceará, Brazil: A hospital-based cross-sectional study.

Authors:  Francisca Lesse Mary Teixeira Alves; Gabriel Zorello Laporta
Journal:  Heliyon       Date:  2020-07-18

7.  The non-fatal disease burden caused by type 2 diabetes in South Africa, 2009.

Authors:  Melanie Y Bertram; Aneil V S Jaswal; Victoria Pillay Van Wyk; Naomi S Levitt; Karen J Hofman
Journal:  Glob Health Action       Date:  2013-01-24       Impact factor: 2.640

8.  Cost-effectiveness of a national population-based screening program for type 2 diabetes: the Brazil experience.

Authors:  Cristiana M Toscano; Xiaohui Zhuo; Kumiko Imai; Bruce B Duncan; Carísi A Polanczyk; Ping Zhang; Michael Engelgau; Maria Inês Schmidt
Journal:  Diabetol Metab Syndr       Date:  2015-10-31       Impact factor: 3.320

9.  Heart rate variability based on risk stratification for type 2 diabetes mellitus.

Authors:  Julia Silva-E-Oliveira; Pâmela Marina Amélio; Isabela Lopes Laguardia Abranches; Dênis Derly Damasceno; Fabianne Furtado
Journal:  Einstein (Sao Paulo)       Date:  2017 Apr-Jun

10.  Forecasting future prevalence of type 2 diabetes mellitus in Syria.

Authors:  Radwan Al Ali; Fawaz Mzayek; Samer Rastam; Fouad M Fouad; Martin O'Flaherty; Simon Capewell; Wasim Maziak
Journal:  BMC Public Health       Date:  2013-05-25       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.